Breast and Prostate Cancer Productivity Costs- A Comparison of the Human Capital Approach and the Friction Cost Approach

May 1, 2012, 00:00 AM
10.1016/j.jval.2011.12.012
https://www.valueinhealthjournal.com/article/S1098-3015(12)00012-5/fulltext
Section Title : Economic Evaluation
Section Order : 4
First Page : 429

Objectives

Productivity costs constitute a substantial proportion of the total societal costs associated with cancer. We compared the results of applying two different analytical methods—the traditional human capital approach (HCA) and the emerging friction cost approach (FCA)—to estimate breast and prostate cancer productivity costs in Ireland in 2008.

Methods

Data from a survey of breast and prostate cancer patients were combined with population-level survival estimates and a national wage data set to calculate costs of temporary disability (cancer-related work absence), permanent disability (workforce departure, reduced working hours), and premature mortality.

Results

For breast cancer, productivity costs per person using the HCA were €193,425 and those per person using the FCA were €8,103; for prostate cancer, the comparable estimates were €109,154 and €8,205, respectively. The HCA generated higher costs for younger patients (breast cancer) because of greater lifetime earning potential. In contrast, the FCA resulted in higher productivity costs for older male patients (prostate cancer) commensurate with higher earning capacity over a shorter time period. Reduced working hours postcancer was a key driver of total HCA productivity costs. HCA costs were sensitive to assumptions about discount and growth rates. FCA costs were sensitive to assumptions about the friction period.

Conclusions

The magnitude of the estimates obtained in this study illustrates the importance of including productivity costs when considering the economic impact of illness. Vastly different results emerge from the application of the HCA and the FCA, and this finding emphasizes the importance of choosing the study perspective carefully and being explicit about assumptions that underpin the methods.

https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00012-5&doi=10.1016/j.jval.2011.12.012
HEOR Topics :
  • Cost/Cost of Illness/Resource Use Studies
  • Economic Evaluation
  • Oncology
  • Specific Diseases & Conditions
  • Work & Home Productivity - Indirect Costs
Tags :
  • burden of illness
  • cancer
  • friction cost approach
  • human capital approach
  • productivity costs
Regions :
  • Africa
  • Eastern and Central Europe
  • Middle East
  • Western Europe